I just read on face book that CDK inhibitor Ribociclib has been rejected for listing on the PBS. This is very very disappointing news when we have metastatic breast cancer and are always hoping that some new treatment will come along and when it does it is un affordable . It makes you think what is the point of hoping. I am 71yrs old and have live a good life, but there are alot of younger woman who have young families that would benefit the extra time that hopefully these new drugs would give them . Why do they do this?
Hey! You will be signed out in 60 seconds due to inactivity. Click here to continue using the site.